{"id":9408,"date":"2025-07-17T09:20:02","date_gmt":"2025-07-17T14:20:02","guid":{"rendered":"https:\/\/fifarma.org\/?p=9408"},"modified":"2025-07-17T09:20:34","modified_gmt":"2025-07-17T14:20:34","slug":"reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina","status":"publish","type":"post","link":"https:\/\/fifarma.org\/pt\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/","title":{"rendered":"Reliance: M\u00e1s cerca del Acceso Oportuno a Medicamentos en Am\u00e9rica Latina"},"content":{"rendered":"
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

En Am\u00e9rica Latina, el acceso a medicamentos innovadores no siempre avanza al mismo ritmo que la ciencia. Si bien tratamientos para enfermedades oncol\u00f3gicas, cardiovasculares, neurol\u00f3gicas, autoinmunes y raras est\u00e1n disponibles en otras regiones, los pacientes latinoamericanos a\u00fan enfrentan largos periodos de espera para beneficiarse de estos avances[1]<\/a>.<\/p>\n\n\n\n

Para reducir esta brecha, en FIFARMA nos hemos sumado a las recomendaciones de la Organizaci\u00f3n Mundial de la Salud, apoyando el uso de herramientas como el reliance<\/em> regulatorio: una de las estrategias m\u00e1s efectivas para fortalecer las capacidades de los sistemas regulatorios y acelerar el acceso oportuno a terapias seguras y de calidad[2]<\/a>.<\/p>\n<\/div>\n<\/div>\n\n\n\n

Este mecanismo permite que las autoridades nacionales se basen en decisiones previamente adoptadas por agencias con altos est\u00e1ndares t\u00e9cnicos, como la FDA de los Estados Unidos o la Agencia Europea de Medicamentos (EMA), para autorizar medicamentos a nivel local. No se trata de delegar responsabilidades, sino de aprovechar evaluaciones ya validadas, optimizar recursos y enfocar los esfuerzos en lo esencial: que los tratamientos lleguen m\u00e1s r\u00e1pido a quienes los necesitan.<\/p>\n\n\n\n

Desde FIFARMA apoyamos a las agencias regulatorias nacionales en el fortalecimiento de sus capacidades t\u00e9cnicas y fomentamos el di\u00e1logo colaborativo para agilizar procesos sin comprometer la calidad ni la seguridad. En un contexto regional donde los recursos deben utilizarse estrat\u00e9gicamente, este tipo de cooperaci\u00f3n representa una v\u00eda inteligente y sostenible para avanzar hacia sistemas de salud m\u00e1s eficientes.<\/p>\n\n\n\n

M\u00e1s all\u00e1 de los procesos, el reliance<\/em> tiene un impacto directo en las personas. Cada d\u00eda de espera representa una oportunidad perdida. Este mecanismo permite reducir a\u00f1os a meses en la disponibilidad de tratamientos innovadores. As\u00ed lo demostr\u00f3 la pandemia por COVID-19, cuando varios pa\u00edses latinoamericanos utilizaron el reliance<\/em> para aprobar vacunas en tiempo r\u00e9cord.<\/p>\n\n\n\n

Los beneficios tambi\u00e9n se extienden a los sistemas de salud y a la industria, al generar mayor previsibilidad, mejor planificaci\u00f3n y una capacidad de respuesta m\u00e1s \u00e1gil ante emergencias sanitarias. En este contexto, en FIFARMA actuamos como un puente entre los actores clave del ecosistema, apoyando modelos regulatorios colaborativos, modernos y centrados en las personas.<\/p>\n\n\n\n

Porque al final, mejorar la vida de los pacientes es el verdadero objetivo. Y si existe una v\u00eda para lograrlo de manera m\u00e1s r\u00e1pida y con garant\u00edas, debemos recorrerla. El reliance<\/em> no es solo una herramienta t\u00e9cnica: es una oportunidad concreta para transformar la salud en Am\u00e9rica Latina.<\/p>\n\n\n\n

\n\n\n\n

[1]<\/a> QVIA & FIFARMA. (2025). An\u00e1lisis del tiempo de espera para el acceso a medicamentos innovadores en Am\u00e9rica Latina: Informe WAIT 2025<\/em>. https:\/\/fifarma.org\/wp-content\/uploads\/2025\/06\/IQVIA-FIFARMA-WAIT-2025-ESP.pdf<\/a><\/p>\n\n\n\n

[2]<\/a> Organizaci\u00f3n Panamericana de la Salud. (2021). Buenas pr\u00e1cticas de utilizaci\u00f3n de decisiones regulatorias de otras jurisdicciones en la regulaci\u00f3n de productos m\u00e9dicos: Principios y consideraciones de alto nivel<\/em> (Anexo 10, en WHO Expert Committee on Specifications for Pharmaceutical Preparations: fifty-fifth report<\/em>, WHO Technical Report Series No. 1033). https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/57165\/9789275326763_spa.pdf?sequence=6<\/a><\/p>\n\n

\n\n\t\t\n
    \n\t\t\t <\/ul>\n <\/div>","protected":false},"excerpt":{"rendered":"

    En Am\u00e9rica Latina, el acceso a medicamentos innovadores no siempre avanza al mismo ritmo que la ciencia. Si bien tratamientos para enfermedades oncol\u00f3gicas, cardiovasculares, neurol\u00f3gicas, autoinmunes y raras est\u00e1n disponibles en otras regiones, los pacientes latinoamericanos a\u00fan enfrentan largos periodos de espera para beneficiarse de estos avances[1]. Para reducir esta brecha, en FIFARMA nos hemos […]<\/p>","protected":false},"author":24,"featured_media":9410,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"enableOnePageScrollInPage":false,"onePageScrollCss":"","onePageScrollSpeed":1000,"onePageScrollAnimation":"easeInOutQuad","onePageScrollShowDotNavigation":true,"onePageScrollNavigation":"scaleUp","onePageScrollNavigationPosition":"right","onePageScrollNavigationHorizontal":[],"onePageScrollNavigationVertical":[],"onePageScrollNavigationSpacing":[],"onePageScrollNavigationColor":"#00ff0d","onePageScrollNavigationColorHover":"#00ff0d","onePageScrollNavigationColorActive":"#00ff0d","onePageScrollNavigationIcon":[],"onePageScrollNavigationWidth":[],"onePageScrollNavigationWidthHover":[],"onePageScrollNavigationWidthActive":[],"onePageScrollNavigationHeight":[],"onePageScrollNavigationHeightHover":[],"onePageScrollNavigationHeightActive":[],"onePageScrollNavigationBorder":[],"onePageScrollNavigationBorderHover":[],"onePageScrollNavigationBorderActive":[],"onePageScrollNavigationBorderRadius":[],"onePageScrollNavigationBorderRadiusHover":[],"onePageScrollNavigationBorderRadiusActive":[],"onePageScrollNavigationTooltipTypography":[],"onePageScrollNavigationTooltipColor":"#ffffff","onePageScrollNavigationTooltipColorHover":"","onePageScrollNavigationTooltipBgColor":"#00ff0d","onePageScrollNavigationTooltipBgColorHover":"","onePageScrollNavigationTooltipPadding":[],"onePageScrollNavigationTooltipPaddingHover":[],"onePageScrollNavigationTooltipBorderRadius":[],"onePageScrollNavigationTooltipBorderRadiusHover":[],"pageSettingsCustomCss":"","footnotes":""},"categories":[177,6],"tags":[26,60,54,49],"class_list":["post-9408","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-comunicado","category-publicaciones","tag-america-latina","tag-fifarma","tag-innovacion","tag-salud"],"yoast_head":"\nReliance: M\u00e1s cerca del Acceso Oportuno a Medicamentos en Am\u00e9rica Latina - FIFARMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fifarma.org\/pt\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Reliance: M\u00e1s cerca del Acceso Oportuno a Medicamentos en Am\u00e9rica Latina\" \/>\n<meta property=\"og:description\" content=\"En Am\u00e9rica Latina, el acceso a medicamentos innovadores no siempre avanza al mismo ritmo que la ciencia. Si bien tratamientos para enfermedades oncol\u00f3gicas, cardiovasculares, neurol\u00f3gicas, autoinmunes y raras est\u00e1n disponibles en otras regiones, los pacientes latinoamericanos a\u00fan enfrentan largos periodos de espera para beneficiarse de estos avances[1]. Para reducir esta brecha, en FIFARMA nos hemos […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fifarma.org\/pt\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/\" \/>\n<meta property=\"og:site_name\" content=\"FIFARMA\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-17T14:20:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-17T14:20:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fifarma.org\/wp-content\/uploads\/2025\/07\/1a663307-bd91-4ebf-a855-ea540b8f2e39-TICKET.hs_file_upload-Blog-Reliance_Banner-Blog-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1138\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"fifarmacomunicaciones\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"fifarmacomunicaciones\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\\\/\"},\"author\":{\"name\":\"fifarmacomunicaciones\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/person\\\/f1731f7484686defa417316a8fe42068\"},\"headline\":\"Reliance: M\u00e1s cerca del Acceso Oportuno a Medicamentos en Am\u00e9rica Latina\",\"datePublished\":\"2025-07-17T14:20:02+00:00\",\"dateModified\":\"2025-07-17T14:20:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\\\/\"},\"wordCount\":531,\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/1a663307-bd91-4ebf-a855-ea540b8f2e39-TICKET.hs_file_upload-Blog-Reliance_Banner-Blog-scaled.jpg\",\"keywords\":[\"america latina\",\"fifarma\",\"innovaci\u00f3n\",\"salud\"],\"articleSection\":[\"Comunicado\",\"Publicaciones\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\\\/\",\"name\":\"Reliance: M\u00e1s cerca del Acceso Oportuno a Medicamentos en Am\u00e9rica Latina - FIFARMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/1a663307-bd91-4ebf-a855-ea540b8f2e39-TICKET.hs_file_upload-Blog-Reliance_Banner-Blog-scaled.jpg\",\"datePublished\":\"2025-07-17T14:20:02+00:00\",\"dateModified\":\"2025-07-17T14:20:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fifarma.org\\\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/1a663307-bd91-4ebf-a855-ea540b8f2e39-TICKET.hs_file_upload-Blog-Reliance_Banner-Blog-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/1a663307-bd91-4ebf-a855-ea540b8f2e39-TICKET.hs_file_upload-Blog-Reliance_Banner-Blog-scaled.jpg\",\"width\":2560,\"height\":1138},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fifarma.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Reliance: M\u00e1s cerca del Acceso Oportuno a Medicamentos en Am\u00e9rica Latina\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"name\":\"FIFARMA\",\"description\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fifarma.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\",\"name\":\"Fifarma\",\"alternateName\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"width\":195,\"height\":39,\"caption\":\"Fifarma\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/person\\\/f1731f7484686defa417316a8fe42068\",\"name\":\"fifarmacomunicaciones\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g\",\"caption\":\"fifarmacomunicaciones\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Reliance: M\u00e1s cerca del Acceso Oportuno a Medicamentos en Am\u00e9rica Latina - FIFARMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fifarma.org\/pt\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/","og_locale":"pt_BR","og_type":"article","og_title":"Reliance: M\u00e1s cerca del Acceso Oportuno a Medicamentos en Am\u00e9rica Latina","og_description":"En Am\u00e9rica Latina, el acceso a medicamentos innovadores no siempre avanza al mismo ritmo que la ciencia. Si bien tratamientos para enfermedades oncol\u00f3gicas, cardiovasculares, neurol\u00f3gicas, autoinmunes y raras est\u00e1n disponibles en otras regiones, los pacientes latinoamericanos a\u00fan enfrentan largos periodos de espera para beneficiarse de estos avances[1]. Para reducir esta brecha, en FIFARMA nos hemos […]","og_url":"https:\/\/fifarma.org\/pt\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/","og_site_name":"FIFARMA","article_published_time":"2025-07-17T14:20:02+00:00","article_modified_time":"2025-07-17T14:20:34+00:00","og_image":[{"width":2560,"height":1138,"url":"https:\/\/fifarma.org\/wp-content\/uploads\/2025\/07\/1a663307-bd91-4ebf-a855-ea540b8f2e39-TICKET.hs_file_upload-Blog-Reliance_Banner-Blog-scaled.jpg","type":"image\/jpeg"}],"author":"fifarmacomunicaciones","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"fifarmacomunicaciones","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fifarma.org\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/#article","isPartOf":{"@id":"https:\/\/fifarma.org\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/"},"author":{"name":"fifarmacomunicaciones","@id":"https:\/\/fifarma.org\/#\/schema\/person\/f1731f7484686defa417316a8fe42068"},"headline":"Reliance: M\u00e1s cerca del Acceso Oportuno a Medicamentos en Am\u00e9rica Latina","datePublished":"2025-07-17T14:20:02+00:00","dateModified":"2025-07-17T14:20:34+00:00","mainEntityOfPage":{"@id":"https:\/\/fifarma.org\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/"},"wordCount":531,"publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"image":{"@id":"https:\/\/fifarma.org\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/#primaryimage"},"thumbnailUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2025\/07\/1a663307-bd91-4ebf-a855-ea540b8f2e39-TICKET.hs_file_upload-Blog-Reliance_Banner-Blog-scaled.jpg","keywords":["america latina","fifarma","innovaci\u00f3n","salud"],"articleSection":["Comunicado","Publicaciones"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/fifarma.org\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/","url":"https:\/\/fifarma.org\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/","name":"Reliance: M\u00e1s cerca del Acceso Oportuno a Medicamentos en Am\u00e9rica Latina - FIFARMA","isPartOf":{"@id":"https:\/\/fifarma.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fifarma.org\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/#primaryimage"},"image":{"@id":"https:\/\/fifarma.org\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/#primaryimage"},"thumbnailUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2025\/07\/1a663307-bd91-4ebf-a855-ea540b8f2e39-TICKET.hs_file_upload-Blog-Reliance_Banner-Blog-scaled.jpg","datePublished":"2025-07-17T14:20:02+00:00","dateModified":"2025-07-17T14:20:34+00:00","breadcrumb":{"@id":"https:\/\/fifarma.org\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fifarma.org\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/fifarma.org\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/#primaryimage","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2025\/07\/1a663307-bd91-4ebf-a855-ea540b8f2e39-TICKET.hs_file_upload-Blog-Reliance_Banner-Blog-scaled.jpg","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2025\/07\/1a663307-bd91-4ebf-a855-ea540b8f2e39-TICKET.hs_file_upload-Blog-Reliance_Banner-Blog-scaled.jpg","width":2560,"height":1138},{"@type":"BreadcrumbList","@id":"https:\/\/fifarma.org\/reliance-mas-cerca-del-acceso-oportuno-a-medicamentos-en-america-latina\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fifarma.org\/"},{"@type":"ListItem","position":2,"name":"Reliance: M\u00e1s cerca del Acceso Oportuno a Medicamentos en Am\u00e9rica Latina"}]},{"@type":"WebSite","@id":"https:\/\/fifarma.org\/#website","url":"https:\/\/fifarma.org\/","name":"FIFARMA","description":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fifarma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/fifarma.org\/#organization","name":"Fifarma","alternateName":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","url":"https:\/\/fifarma.org\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","width":195,"height":39,"caption":"Fifarma"},"image":{"@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/fifarma.org\/#\/schema\/person\/f1731f7484686defa417316a8fe42068","name":"fifarmacomunicaciones","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g","caption":"fifarmacomunicaciones"}}]}},"_links":{"self":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/posts\/9408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/comments?post=9408"}],"version-history":[{"count":0,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/posts\/9408\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/media\/9410"}],"wp:attachment":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/media?parent=9408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/categories?post=9408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/tags?post=9408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}